Literature DB >> 2050683

Caldesmon phosphorylation in intact human platelets by cAMP-dependent protein kinase and protein kinase C.

J M Hettasch1, J R Sellers.   

Abstract

Caldesmon is a calmodulin- and actin-binding protein present in both smooth and non-muscle tissue. The present study demonstrates that platelet caldesmon is a substrate for cAMP-dependent protein kinase (protein kinase A). Purified platelet caldesmon has an apparent molecular mass of 82 kDa on sodium dodecyl sulfate-polyacrylamide gels and can be phosphorylated in vitro by the catalytic subunit of protein kinase A to a level of 2 mol of phosphate/mol of caldesmon. Phosphorylation of caldesmon by protein kinase A results in a shift in the apparent molecular mass of the protein to 86 kDa. When caldesmon was immunoprecipitated from intact platelets treated with prostacyclin (PGI2) the same shift in apparent molecular mass of caldesmon was observed. Comparison of two-dimensional tryptic phosphopeptide maps of caldesmon phosphorylated in vitro by protein kinase A with caldesmon immunoprecipitated from intact platelets verified that protein kinase A was responsible for the observed increase in caldesmon phosphorylation in PGI2-treated platelets. The present study demonstrates that although caldesmon is basally phosphorylated in the intact platelet, activation of protein kinase A by PGI2 results in the significant incorporation of phosphate into two new sites. In addition, the effects of phorbol ester, collagen, and thrombin on caldesmon phosphorylation were also examined. Although phorbol ester treatment results in a significant increase in caldesmon phosphorylation apparently by protein kinase C, treatment of intact platelets with thrombin or collagen does not result in an increase in caldesmon phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2050683

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  A low molecular weight substance purified from human placenta inhibits cAMP-dependent protein kinase and activates protein kinase C.

Authors:  N Talwar; R B Pilz; Z Yu; A Burlingame; G R Boss
Journal:  Mol Cell Biochem       Date:  1997-05       Impact factor: 3.396

2.  Phosphorylation of aorta caldesmon by endogenous proteolytic fragments of protein kinase C.

Authors:  A V Vorotnikov; N B Gusev; S Hua; J H Collins; C S Redwood; S B Marston
Journal:  J Muscle Res Cell Motil       Date:  1994-02       Impact factor: 2.698

3.  Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display.

Authors:  L P Aiello; G S Robinson; Y W Lin; Y Nishio; G L King
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

Review 4.  Diversification of caldesmon-linked actin cytoskeleton in cell motility.

Authors:  Taira Mayanagi; Kenji Sobue
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

5.  Reversal of caldesmon binding to myosin with calcium-calmodulin or by phosphorylating caldesmon.

Authors:  M E Hemric; F W Lu; R Shrager; J Carey; J M Chalovich
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

6.  Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.

Authors:  Wei Zhang; Robert W Colman
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

7.  Canine mesenteric artery and vein convey no difference in the content of major contractile proteins.

Authors:  Ilia A Yamboliev; Sean M Ward; Violeta N Mutafova-Yambolieva
Journal:  BMC Physiol       Date:  2002-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.